Open AccessP659: IBRUTINIB IN OVER‐EIGHTIES PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA: A MULTICENTER ITALIAN COHORT
Author(s) -
Reda G.,
Mattiello V.,
Frustaci A. M.,
Visentin A.,
Mauro F. R.,
Innocenti I.,
Gentile M.,
Giannarelli D.,
Noto A.,
Cassin R.,
Laurenti L.,
Tedeschi A.
Publication year - 2022
Publication title -
hemasphere
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.677
H-Index - 11
ISSN - 2572-9241
DOI - 10.1097/01.hs9.0000845520.36920.db
Subject(s) - ibrutinib , medicine , discontinuation , neutropenia , clinical endpoint , chronic lymphocytic leukemia , cohort , adverse effect , leukemia , clinical trial , chemotherapy